期刊文献+

ICU重度有机磷中毒患者血清降钙素原测定与医院感染的临床研究 被引量:2

Clinical study between determination of procalcitonin and nosocomial infection in patients with severe organophosphorus poisoning in ICU
原文传递
导出
摘要 目的探讨血清降钙素原(procalcitonin,PCT)测定在重症监护病房(ICU)重度有机磷中毒患者医院感染中的临床意义。方法选取重度有机磷中毒患者107例,采用半定量固相免疫色谱法(PCT—Q)动态监测血清PCT浓度,同时分析医院感染的情况。结果ICU重毒有机磷中毒患者医院感染率为43.8%,感染组与对照组血清PCT浓度比较差异有统计学意义(P〈0.01),PCT〉0.5ng/ml预测医院感染的敏感度、特异度、阳性预测值、阴性预测值分别为95.65%、81.83%、80%、96.15%。对PCT阳性患者使用适当抗生素治疗3—7d后,PCT转为正常(〈0.5ng/m1)。结论血清降钙素原测定对ICU重毒有机磷中毒患者院内感染早期诊断及临床抗生素治疗有指导意义。 Objective To explore the clinical significance of serum procalcitonin (PCT) levels in severe organophosphorus poisoning patients with nosocomial infection in ICU. Methods One hundred and seven patients were selected and monitored PCT concentration using semiquantitative solidphase im- mune ehomatography(PCT-Q) and nosocomial infection. Results The rate of nosocomial infection was 43 % in severe organophosphorus poisoning patients. The difference of PCT concentration was statistically significant ( P 〈 0.01 ) between infection group and control group. The sensitivity, specificity, and posi- tive and negative predictive values of nosocomial infection prediction with PCT 〉0. 5 ng/ml were 95.65% ,81.83% ,80% and 96.15% , respectively. PCT values returned to normal( 〈0, 5 ng/ml) by 3 to 7 days of appropriate antibiotic therapy. Conclusions For severe organophosphorus poisoning patients in ICU, monitoring PCT level could help find and distinguish nosocomia] infection at an earlier stage and guide the application of antibiotics.
出处 《中国实用医刊》 2012年第23期49-51,共3页 Chinese Journal of Practical Medicine
关键词 降钙素原 医院感染 ICU 重度有机磷中毒 Procalcitonin Nosocomial infection ICU Severe organophosphorus poisoning
  • 相关文献

参考文献7

二级参考文献27

  • 1许桂英.C反应蛋白水平测定对诊断急性重症胰腺炎的临床意义[J].中国现代药物应用,2009,3(5):108-109. 被引量:6
  • 2刘英.C-反应蛋白在急性胰腺炎诊断中的临床应用体会[J].黑龙江医药科学,2005,28(4):35-35. 被引量:2
  • 3何礼贤.值得研究和借鉴的短程抗菌治疗策略[J].中国抗感染化疗杂志,2005,5(5):318-319. 被引量:20
  • 4贾国葆,吴建胜,黄庆科,陈民新.降钙素原和C反应蛋白在急性胰腺炎中的意义[J].中华内科杂志,2005,44(10):781-782. 被引量:7
  • 5Levy M M, Fink M P, Marshall J C, et al. 2001 SCCM/ESICM/ ACCP/ATS/SIS international sepsis definitions conference [J]. Intensive Care Med, 2003,29 (4) : 530-538.
  • 6Wanner G A, Keel M, Steckholzer U, et al. Relationship between procalcitonin plasma levels and severity of injury, sepsis, organ failure, and mortality in injured patients [J]. Crit Care Med,2000, 28(4) :950-957.
  • 7American Thoracic Society, Infectious Diseases Society. Guidelines for the management of adult with hospital-acquired, ventilatorassociated, and healthcare-associated pneumonia [J]. Am J Respir Crit Care Med, 2005,171 (4) : 388-416.
  • 8Assicot M, Gendrel D, Carsin H, et al. ,High serum procalcitonin concentrations in patients with sepsis and infection [J]. Lancet, 1993, 341 (8844) :515-518.
  • 9Al-Nakeeb S, Clermont G. Procalcitonin testing has the potential to reduce unnecessary antibiotic use in patients with suspected lower respiratory tract infections [ J ]. Crit Care, 2005,9 (3) : E5.
  • 10Bignardi G E, Dhar R, Heycock R, et al. Can procalcitonin testing reduce antibiotic prescribing for respiratory infections [J]? Age Ageing, 2006,35 (6) : 625-626.

共引文献106

同被引文献27

  • 1张代民.降钙素原的测定与临床应用进展[J].实用医药杂志,2007,24(5):619-622. 被引量:57
  • 2Auriti C, Fiscarelli E, Ronchetti MP,et al. Procalcitonin in detectingneonatal nosocomial sepsis [ J ]. Arch Dis Child Fetal Neonatal Ed,2012,97(5) :F368-370.
  • 3Kibe S,Adams K,Barlow G. Diagnostic and prognostic biomarkers of sep-sis in critical care[ J]. J Antimicrob Chemother,2011,66 : ( Suppl 2) :ii33-40.
  • 4Ghorbani G. Procalcitonin role in differential diagnosis of infection sta-ges and non infection inflammation[ J]. Pak J Biol Sci ,2009 ,12(4):393-396.
  • 5Hillas G, Vassilakopoulos T, Plantza P, et al. C-reactive protein andprocalcitonin as predictors of survival and septic shock in ventilator-associated pneumonia[ J] . Eur Respir J ,2010 ,35 ( 4) :805-811.
  • 6Christ-crain M, stolz D, Bingisser R, et al. Procalcitonin guidance ofantibiotic therapy in community-acquired pneumonia: randomizedtrial [ J]. Am J Respir Crit Care Med,2006,174(1) :84-93.
  • 7Nobre V,Harbarth S, Graf JD, et al. Use of procalcitonin to shortenantibiotic treatment duration in septic patients : a randomized trialt J]. Am J Respir Crit Care Med,2008 ,177(5) :498-505.
  • 8张守印,贺金荣,张双宅,刘劼,蔡虹,马凤琴,张建华,海荣,俞东征,徐建国.PCT早期鉴别诊断细菌和病毒感染及其在疾病控制中的应用[J].中国卫生检验杂志,2007,17(12):2235-2237. 被引量:28
  • 9呼新建,常晓悦.降钙素原的研究进展[J].医学综述,2010,16(12):1795-1797. 被引量:97
  • 10王军.有机磷中毒患者血清hs-CRP、IL-6和TNF-α的变化及其临床意义[J].山东医药,2010,50(45):80-81. 被引量:6

引证文献2

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部